FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2770635318> ?p ?o ?g. }

• W2770635318 endingPage "107468" @default.
• W2770635318 startingPage "107462" @default.
• W2770635318 abstract "Tyroid transcription factor-1 (TTF-1) motivates the differentiation and development of bronchioloalveolar cells. The association of TTF-1 expression with prognosis in stage I adenocarcinoma is unclear. This study enrolled patients with resected stage I pulmonary adenocarcinoma who had TTF-1 immunostaining. All the corresponding clinicopathologic data including sex, age, smoking history, pathologic T stage, pathologic disease stage, surgical procedure, subtypes, follow-up records and adjuvant chemotherapy were investigated. Totally, 126 adenocarcinomas with TTF-1- and 2687 adenocarcinomas with TTF-1+ were subjected to the study. Among adenocarcinomas with TTF-1-, the major subtype was acinar-predominant adenocarcinomas, followed by invasive mucinous and papillary subtypes while acinar, papillary and minimally invasive adenocarcinoma were in the majority among adenocarcinomas with TTF-1+. The status of TTF-1 expression was not a significant factor for relapse-free survival (RFS) and overall survival (OS). Furthermore, there was no survival difference between the two groups (RFS: p = 0.2474; OS: p = 0.1480). When confined to stage IB adenocarcinomas with TTF-1-, whether received adjuvant chemotherapy made no difference to RFS and OS (RFS: p = 0.2707; OS: p = 1.000), as was the case in stage IB adenocarcinomas with TTF-1+ (RFS: p = 0.9161; OS: p = 0.1100). Within follow-up period, there was significant difference in post-recurrence survival (PRS) for TTF-1- patients compared with those TTF-1+ patients (Log-rank p = 0.0113). However, regarding to the recurrence site, there was no difference between TTF-1- patients and TTF-1+ patients in patients with stage I adenocarcinoma (p = 0.771) In conclusion, there is no significant difference in RFS and OS between TTF-1- group and TTF-1+ group, but TTF-1 negative adenocarcinoma has significantly worse PFS in patients with stage I adenocarcinoma. Moreover, chemotherapeutic efficacy between TTF-1+ and TTF-1- stage IB adenocarcinomas did not differ." @default.
• W2770635318 created "2017-12-04" @default.
• W2770635318 creator A5005341367 @default.
• W2770635318 creator A5044677624 @default.
• W2770635318 creator A5054697336 @default.
• W2770635318 creator A5083617730 @default.
• W2770635318 date "2017-11-18" @default.
• W2770635318 modified "2023-10-16" @default.
• W2770635318 title "Prognostic relevance of TTF-1 expression in stage I adenocarcinoma" @default.
• W2770635318 cites W1972387812 @default.
• W2770635318 cites W1976697496 @default.
• W2770635318 cites W1985213644 @default.
• W2770635318 cites W1994617578 @default.
• W2770635318 cites W2011192758 @default.
• W2770635318 cites W2021245106 @default.
• W2770635318 cites W2028680169 @default.
• W2770635318 cites W2033438163 @default.
• W2770635318 cites W2037389444 @default.
• W2770635318 cites W2037604791 @default.
• W2770635318 cites W2038752079 @default.
• W2770635318 cites W2043966026 @default.
• W2770635318 cites W2046317081 @default.
• W2770635318 cites W2049674541 @default.
• W2770635318 cites W2085957460 @default.
• W2770635318 cites W2093357370 @default.
• W2770635318 cites W2095635764 @default.
• W2770635318 cites W2106787323 @default.
• W2770635318 cites W2127160299 @default.
• W2770635318 cites W2129802084 @default.
• W2770635318 cites W2132344184 @default.
• W2770635318 cites W2134368652 @default.
• W2770635318 cites W2146040216 @default.
• W2770635318 cites W2151439214 @default.
• W2770635318 cites W2187090435 @default.
• W2770635318 cites W2317017975 @default.
• W2770635318 cites W2597872842 @default.
• W2770635318 cites W4234443475 @default.
• W2770635318 doi "https://doi.org/10.18632/oncotarget.22489" @default.
• W2770635318 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5746080" @default.
• W2770635318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29296178" @default.
• W2770635318 hasPublicationYear "2017" @default.
• W2770635318 type Work @default.
• W2770635318 sameAs 2770635318 @default.
• W2770635318 citedByCount "4" @default.
• W2770635318 countsByYear W27706353182018 @default.
• W2770635318 countsByYear W27706353182019 @default.
• W2770635318 countsByYear W27706353182023 @default.
• W2770635318 crossrefType "journal-article" @default.
• W2770635318 hasAuthorship W2770635318A5005341367 @default.
• W2770635318 hasAuthorship W2770635318A5044677624 @default.
• W2770635318 hasAuthorship W2770635318A5054697336 @default.
• W2770635318 hasAuthorship W2770635318A5083617730 @default.
• W2770635318 hasBestOaLocation W27706353181 @default.
• W2770635318 hasConcept C121608353 @default.
• W2770635318 hasConcept C126322002 @default.
• W2770635318 hasConcept C142724271 @default.
• W2770635318 hasConcept C143998085 @default.
• W2770635318 hasConcept C146357865 @default.
• W2770635318 hasConcept C151730666 @default.
• W2770635318 hasConcept C204232928 @default.
• W2770635318 hasConcept C2776694085 @default.
• W2770635318 hasConcept C2781182431 @default.
• W2770635318 hasConcept C4224716 @default.
• W2770635318 hasConcept C71924100 @default.
• W2770635318 hasConcept C86803240 @default.
• W2770635318 hasConcept C90924648 @default.
• W2770635318 hasConceptScore W2770635318C121608353 @default.
• W2770635318 hasConceptScore W2770635318C126322002 @default.
• W2770635318 hasConceptScore W2770635318C142724271 @default.
• W2770635318 hasConceptScore W2770635318C143998085 @default.
• W2770635318 hasConceptScore W2770635318C146357865 @default.
• W2770635318 hasConceptScore W2770635318C151730666 @default.
• W2770635318 hasConceptScore W2770635318C204232928 @default.
• W2770635318 hasConceptScore W2770635318C2776694085 @default.
• W2770635318 hasConceptScore W2770635318C2781182431 @default.
• W2770635318 hasConceptScore W2770635318C4224716 @default.
• W2770635318 hasConceptScore W2770635318C71924100 @default.
• W2770635318 hasConceptScore W2770635318C86803240 @default.
• W2770635318 hasConceptScore W2770635318C90924648 @default.
• W2770635318 hasIssue "64" @default.
• W2770635318 hasLocation W27706353181 @default.
• W2770635318 hasLocation W27706353182 @default.
• W2770635318 hasLocation W27706353183 @default.
• W2770635318 hasOpenAccess W2770635318 @default.
• W2770635318 hasPrimaryLocation W27706353181 @default.
• W2770635318 hasRelatedWork W2022498945 @default.
• W2770635318 hasRelatedWork W202920663 @default.
• W2770635318 hasRelatedWork W2056351008 @default.
• W2770635318 hasRelatedWork W2134592120 @default.
• W2770635318 hasRelatedWork W2242689536 @default.
• W2770635318 hasRelatedWork W2398317084 @default.
• W2770635318 hasRelatedWork W2407881497 @default.
• W2770635318 hasRelatedWork W2413359840 @default.
• W2770635318 hasRelatedWork W2947306981 @default.
• W2770635318 hasRelatedWork W33978073 @default.
• W2770635318 hasVolume "8" @default.
• W2770635318 isParatext "false" @default.
• W2770635318 isRetracted "false" @default.

• next